EXEL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Exelixis (EXEL) Earnings Date & Reports

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EXEL is expected to report earnings to fall 31.73% to 37 cents per share on May 13

Q1'25

Est.

$0.38

Q4'24

Beat

by $0.16

Q3'24

Beat

by $0.13

Q2'24

Beat

by $0.53

Q1'24

Missed

by $0.06

The last earnings report on February 11 showed earnings per share of 55 cents, beating the estimate of 38 cents. With 1.44M shares outstanding, the current market capitalization sits at 10.96B.

View a ticker or compare two or three

Compare

EXEL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EXEL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for EXEL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of small molecule therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1851 Harbor Bay Parkway

Phone

+1 650 837-7000

Employees

1310

Web

https://www.exelixis.com